{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:51:15Z","timestamp":1791539475079,"version":"4.3.4"},"reference-count":24,"publisher":"Wiley","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EFS2","EFSA Journal"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:p>Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the safety of benfotiamine as a novel food (NF) pursuant to Regulation (EU) 2015\/2283 and on the bioavailability of benfotiamine as a source of thiamin in the context of Directive 2002\/46\/EC. The NF, which is produced by chemical synthesis, is proposed to be used in food supplements for adults at a maximum intake of 300 mg\/day. The Panel notes that the identity of the NF has not been sufficiently demonstrated, including the possible presence of small particles and nanoparticles. The Panel also notes that the data provided were insufficient to demonstrate that the manufacturing process is reproducible and capable of consistently producing a product with the proposed characteristics. No conclusion could be drawn on the microbiological stability of the NF over the proposed shelf life. The information provided indicates that the bioavailability of thiamin from benfotiamine may be higher than that from water\u2010soluble forms of thiamin and thus benfotiamine may be used as a source of thiamin. Owing to the insufficient characterisation of the NF, unresolved uncertainties regarding small particles, including nanoparticles, the lack of adequate information on its metabolic fate, bioaccumulation and long\u2010term effects, and the limitations of the submitted toxicological data, the Panel concludes that the safety of benfotiamine as a NF cannot be established under the proposed conditions of use. The Panel also concludes that the higher bioavailability of benfotiamine compared with authorised or natural sources of thiamin has not been quantified to an extent that would allow the derivation of a conversion factor for labelling purposes.<\/jats:p>","DOI":"10.2903\/j.efsa.2026.10301","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:17:21Z","timestamp":1791537441000},"source":"Crossref","is-referenced-by-count":0,"title":["Safety of benfotiamine as a Novel food pursuant to Regulation (EU) 2015\/2283 and the bioavailability of benfotiamine as a source of thiamin in the context of Directive 2002\/46\/EC on food supplements"],"prefix":"10.2903","volume":"24","author":[{"name":"EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Turck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Bohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monta\u00f1a","family":"C\u00e1mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Castenmiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefaan","family":"De Henauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngeles","family":"Jos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Maciuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Mangelsdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breige","family":"McNulty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Androniki","family":"Naska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Pentieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Siani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Thies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cubadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Frenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Gundert\u2010Remy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Marcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J.","family":"McArdle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Neuh\u00e4user\u2010Berthold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Prieto","family":"Maradona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Siskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Precup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Valtue\u00f1a","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Schmierer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Ildico","family":"Hirsch\u2010Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"issue":"11\u201312","key":"10.2903\/j.efsa.2026.10301_ref1","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1080\/10826076.2021.2016443","article-title":"HPLC determination of pKa value of benfotiamine","volume":"44","author":"Angelov","year":"2021","journal-title":"Journal of Liquid Chromatography & Related Technologies"},{"issue":"5","key":"10.2903\/j.efsa.2026.10301_ref2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000177659","article-title":"Bioavailability assessment of the lipophilic benfotiamine as compared to a water\u2010soluble thiamin derivative","volume":"35","author":"Bitsch","year":"1991","journal-title":"Annals of Nutrition and Metabolism"},{"key":"#cr-split#-10.2903\/j.efsa.2026.10301_ref3.1","unstructured":"EFSA (European Food Safety Authority) . (2021). Administrative guidance for the preparation of applications on novel foods pursuant to article 10 of regulation"},{"key":"#cr-split#-10.2903\/j.efsa.2026.10301_ref3.2","unstructured":"(EU) 2015\/2283. EFSA Supporting Publications, 18(3), EN\u20106488. https:\/\/doi.org\/10.2903\/sp.efsa.2021.EN\u20106488"},{"key":"10.2903\/j.efsa.2026.10301_ref4","doi-asserted-by":"crossref","unstructured":"EFSA ANS Panel (EFSA Panel on Food Additives and Nutrient Sources Added to Food) . (2008). Scientific Opinion of the panel on food additives and nutrient sources added to food (ANS) on a request from the commission on benfotiamine, thiamine monophosphate chloride and thiamine pyrophosphate chloride, as sources of vitamin B1. EFSA Journal, 864. https:\/\/doi.org\/10.2903\/j.efsa.2008.864","DOI":"10.2903\/j.efsa.2008.864"},{"key":"10.2903\/j.efsa.2026.10301_ref5","doi-asserted-by":"crossref","unstructured":"EFSA ANS Panel (EFSA Panel on Food Additives and Nutrient Sources Added to Food) . (2016). Scientific Opinion on the re\u2010evaluation of benzoic acid (E 210), sodium benzoate (E 211), potassium benzoate (E 212) and calcium benzoate (E 213) as food additives. EFSA Journal, 14(3), 4433. https:\/\/doi.org\/10.2903\/j.efsa.2016.4433","DOI":"10.2903\/j.efsa.2016.4433"},{"key":"10.2903\/j.efsa.2026.10301_ref6","doi-asserted-by":"crossref","unstructured":"EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies) . (2016a). Guidance on the preparation and presentation of an application for authorisation of a novel food in the context of regulation (EU) 2015\/2283. EFSA Journal, 14(11), 4594. https:\/\/doi.org\/10.2903\/j.efsa.2016.4594","DOI":"10.2903\/j.efsa.2016.4594"},{"key":"10.2903\/j.efsa.2026.10301_ref7","doi-asserted-by":"crossref","unstructured":"EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies) . (2016b). Scientific opinion on dietary reference values for thiamin. EFSA Journal, 14(12), 4653. https:\/\/doi.org\/10.2903\/j.efsa.2016.4653","DOI":"10.2903\/j.efsa.2016.4484"},{"key":"10.2903\/j.efsa.2026.10301_ref8","doi-asserted-by":"crossref","unstructured":"EFSA NDA Panel (EFSA Panel on Nutrition, Novel Foods and Food Allergens) . (2024). Guidance on scientific principles and data requirements for the safety and relative bioavailability assessment of new micronutrient sources. EFSA Journal, 22(8), 8946. https:\/\/doi.org\/10.2903\/j.efsa.2024.8946","DOI":"10.2903\/j.efsa.2024.8946"},{"key":"10.2903\/j.efsa.2026.10301_ref9","doi-asserted-by":"crossref","unstructured":"EFSA Scientific Committee . (2021a). Guidance on technical requirements for regulated food and feed product applications to establish the presence of small particles including nanoparticles. EFSA Journal, 19(8), 6769. https:\/\/doi.org\/10.2903\/j.efsa.2021.6769","DOI":"10.2903\/j.efsa.2021.6769"},{"key":"10.2903\/j.efsa.2026.10301_ref10","doi-asserted-by":"crossref","unstructured":"EFSA Scientific Committee . (2021b). Guidance on risk assessment of nanomaterials to be applied in the food and feed chain: Human and animal health. EFSA Journal, 19(8), 6768. https:\/\/doi.org\/10.2903\/j.efsa.2021.6768","DOI":"10.2903\/j.efsa.2021.6768"},{"key":"10.2903\/j.efsa.2026.10301_ref11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1024\/0300-9831.70.6.311","article-title":"Bioavailability of water\u2010 and lipid\u2010soluble thiamine compounds in broiler chickens","volume":"70","author":"Geyer","year":"2000","journal-title":"International Journal for Vitamin and Nutrition Research"},{"issue":"4","key":"10.2903\/j.efsa.2026.10301_ref12","first-page":"2016","article-title":"Comparative bioavailability of various thiamine derivates after oral administration","volume":"36","author":"Greb","year":"1998","journal-title":"International Journal of Clinical Pharmacology, Therapy, and Toxicology"},{"key":"10.2903\/j.efsa.2026.10301_ref13","unstructured":"JECFA (Joint FAO\/WHO Expert Committee on Food Additives) . (2021). WHO Technical Report Series 1037. Evaluation of certain food additives. Ninety\u2010second report of the Joint FAO\/WHO Expert Committee on Food Additives."},{"key":"10.2903\/j.efsa.2026.10301_ref14","doi-asserted-by":"crossref","unstructured":"Jonus, H. C., Byrnes, C. C., Kim, J., Valle, M. L., Bartlett, M. G., Said, H. M., & Zastre, J. A. (2020). Thiamine mimetics sulbutiamine and benfotiamine as a nutraceutical approach to anticancer therapy. Biomedicine and Pharmacotherapy, 121, 109648. https:\/\/doi.org\/10.1016\/j.biopha.2019.109648","DOI":"10.1016\/j.biopha.2019.109648"},{"issue":"2","key":"10.2903\/j.efsa.2026.10301_ref15","first-page":"47","article-title":"Pharmacokinetics of thiamine derivatives especially of benfotiamine","volume":"34","author":"Loew","year":"1996","journal-title":"The International Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.2903\/j.efsa.2026.10301_ref16","first-page":"11","volume-title":"OECD guidelines for the testing of chemicals, section\u00a04","author":"OECD (Organisation for Economic Co\u2010Operation and Development)","year":"1997"},{"key":"10.2903\/j.efsa.2026.10301_ref17","unstructured":"SCF (Scientific Committee on Food) . (2001). Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Vitamin B1 (expressed on 11 July 2001). SCF\/CS\/NUT\/UPPLEV\/46 Final 16 July 2001. https:\/\/ec.europa.eu\/food\/sites\/food\/files\/safety\/docs\/scicom_scf_out93_en.pdf"},{"issue":"5","key":"10.2903\/j.efsa.2026.10301_ref18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/dmrr.860","article-title":"Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in\u00a0vitro","volume":"24","author":"Schmid","year":"2008","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"key":"10.2903\/j.efsa.2026.10301_ref19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2147\/DDDT.S296197","article-title":"Safety, tolerability and pharmacokinetics of single and multiple ascending doses of Benfotiamine in healthy subjects","volume":"15","author":"Sheng","year":"2021","journal-title":"Drug Design, Development and Therapy"},{"key":"10.2903\/j.efsa.2026.10301_ref20","unstructured":"Szirmai, E., Szirmai, M., McGuigan, F. J., & Klosa, J. (1977). Untersuchungen zur Toxizit\u00e4t des Thiamindisulfid\u2010monoorotat. Kurze Mitteilung [Studies on the toxicity of thiaminedisulfide monoorotate. Short communication]. Arzneimittel\u2010Forschung, 27(10), 1998 German."},{"key":"10.2903\/j.efsa.2026.10301_ref21","doi-asserted-by":"crossref","unstructured":"Volvert, M. L., Seyen, S., Piette, M., Evrard, B., Gangolf, M., Plumier, J. C., & Bettendorff, L. (2008). Benfotiamine, a synthetic S\u2010acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid\u2010soluble thiamine disulfide derivatives. BMC Pharmacology, 8, 10. https:\/\/doi.org\/10.1186\/1471\u20102210\u20108\u201010","DOI":"10.1186\/1471-2210-8-10"},{"issue":"6","key":"10.2903\/j.efsa.2026.10301_ref22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/alcalc\/33.6.631","article-title":"Benfotiamine in treatment of alcoholic polyneuropathy: An 8\u2010week randomized controlled study (BAP I study)","volume":"33","author":"Woelk","year":"1998","journal-title":"Alcohol and Alcoholism"},{"issue":"6","key":"10.2903\/j.efsa.2026.10301_ref23","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jcph.261","article-title":"Pharmacokinetic study of benfotiamine and the bioavailability assessment compared to thiamine hydrochloride","volume":"54","author":"Xie","year":"2014","journal-title":"Journal of Clinical Pharmacology"}],"container-title":["EFSA Journal"],"original-title":[],"link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.2903\/j.efsa.2026.10301","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.2903\/j.efsa.2026.10301\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:17:28Z","timestamp":1791537448000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.2903\/j.efsa.2026.10301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"journal-issue":{"issue":"10"},"URL":"https:\/\/doi.org\/10.2903\/j.efsa.2026.10301","relation":{},"ISSN":["1831-4732","1831-4732"],"issn-type":[{"value":"1831-4732","type":"print"},{"value":"1831-4732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}